Opposing roles of eosinophils in cancer
Open accessThe DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Eosinophils are a subset of granulocytes mostly known for their ability to combat parasites and induce allergy. Although they were described to be related to cancer more than 100 years ago, their role in tumors is still undefined. Recent observations revealed that they display regulatory functions towards other immune cell subsets in the tumor microenvironment or direct cytotoxic functions against tumor cells, leading to either antitumor or protumor effects. This paradoxical role of eosinophils was suggested to be dependent on the different factors in the TME. In addition, the clinical relevance of these cells has been recently addressed. In most cases, the accumulation of eosinophils both in the tumor tissue, called tumor-associated tissue eosinophilia, and in the peripheral blood were reported to be prognostic markers for a better outcome of cancer patients. In immunotherapy of cancer, particularly in therapy with immune checkpoint inhibitors, eosinophils were even shown to be a potential predictive marker for a beneficial clinical response. A better understanding of their role in cancer progression will help to establish them as prognostic and predictive markers and to design strategies for targeting eosinophils.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Considering that eosinophils can have a role in the response against cancer,17–20 an elevated AEC might be a marker of effectiveness in some patients.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis
Wu, D., Molofsky, A. B., Liang, H.-E., Ricardo-Gonzalez, R. R., Jouihan, H. A., Bando, J. K., Chawla, A., & Locksley, R. M. (2011) · Science · doi:10.1126/science.1201475 · Cited by 1,376
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Nair, P., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E., & O'Byrne, P. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805435 · Cited by 1,356
Rothenberg, M. E., & Hogan, S. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090720 · Cited by 1,356
Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., & Ferrara, G. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020121 · Cited by 1,133
Type 2 innate lymphoid cells control eosinophil homeostasis
Nussbaum, J. C., Van Dyken, S. J., von Moltke, J., Cheng, L. E., Mohapatra, A., Molofsky, A. B., Thornton, E. E., Krummel, M. F., Chawla, A., Liang, H.-E., et al. (2013) · Nature · doi:10.1038/nature12526 · Cited by 1,068
Eosinophils: changing perspectives in health and disease
Rosenberg, H. F., Dyer, K. D., & Foster, P. S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3341 · Cited by 989
Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense
Yousefi, S., Gold, J. A., Andina, N., Lee, J. J., Kelly, A. M., Kozlowski, E., Schmid, I., Straumann, A., Reichenbach, J., Gleich, G. J., et al. (2008) · Nature Medicine · doi:10.1038/nm.1855 · Cited by 967
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
Inflammation and necrosis promote tumour growth
Vakkila, J., & Lotze, M. T. (2004) · Nature Reviews Immunology · doi:10.1038/nri1415 · Cited by 690
Clutterbuck, E., Hirst, E., & Sanderson, C. (1989) · Blood · doi:10.1182/blood.v73.6.1504.1504 · Cited by 687
Collins, P. D., Marleau, S., Griffiths-Johnson, D. A., Jose, P. J., & Williams, T. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.4.1169 · Cited by 658
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
Weide, B., Martens, A., Hassel, J. C., Berking, C., Postow, M. A., Bisschop, K., Simeone, E., Mangana, J., Schilling, B., Di Giacomo, A. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0127 · Cited by 589
Cloning, expression, and characterization of the human eosinophil eotaxin receptor.
Daugherty, B. L., Siciliano, S. J., DeMartino, J. A., Malkowitz, L., Sirotina, A., & Springer, M. S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2349 · Cited by 547
An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4
Tepper, R. I., Coffman, R. L., & Leder, P. (1992) · Science · doi:10.1126/science.1636093 · Cited by 541
Eosinophils are required for the maintenance of plasma cells in the bone marrow
Chu, V. T., Fröhlich, A., Steinhauser, G., Scheel, T., Roch, T., Fillatreau, S., Lee, J. J., Löhning, M., & Berek, C. (2011) · Nature Immunology · doi:10.1038/ni.1981 · Cited by 519
Carretero, R., Sektioglu, I. M., Garbi, N., Salgado, O. C., Beckhove, P., & Hämmerling, G. J. (2015) · Nature Immunology · doi:10.1038/ni.3159 · Cited by 501
Functions of tissue-resident eosinophils
Weller, P. F., & Spencer, L. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.95 · Cited by 480
Gebhardt, C., Sevko, A., Jiang, H., Lichtenberger, R., Reith, M., Tarnanidis, K., Holland-Letz, T., Umansky, L., Beckhove, P., Sucker, A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0676 · Cited by 367
Self-citationThe Biology of the Eosinophilic Leukocyte
Gleich, G. J., Adolphson, C. R., & Leiferman, K. M. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.000505 · Cited by 353
Lymph node trafficking and antigen presentation by endobronchial eosinophils
Shi, H.-Z., Humbles, A., Gerard, C., Jin, Z., & Weller, P. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8945 · Cited by 326
Farne, H. A., Wilson, A., Powell, C., Bax, L., & Milan, S. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010834.pub3 · Cited by 315
Chu, V. T., Beller, A., Rausch, S., Strandmark, J., Zänker, M., Arbach, O., Kruglov, A., & Berek, C. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.014 · Cited by 314
Phipps, S., Lam, C. E., Mahalingam, S., Newhouse, M., Ramirez, R., Rosenberg, H. F., Foster, P. S., & Matthaei, K. I. (2007) · Blood · doi:10.1182/blood-2007-01-071340 · Cited by 305
Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein.
Lehrer, R. I., Szklarek, D., Barton, A., Ganz, T., Hamann, K. J., & Gleich, G. J. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.12.4428 · Cited by 293
Domachowske, J. B., Dyer, K. D., Bonville, C. A., & Rosenberg, H. F. (1998) · The Journal of Infectious Diseases · doi:10.1086/515322 · Cited by 293
Eosinophils: The unsung heroes in cancer?
Varricchi, G., Galdiero, M. R., Loffredo, S., Lucarini, V., Marone, G., Mattei, F., Marone, G., & Schiavoni, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1393134 · Cited by 280
TNF Counterbalances the Emergence of M2 Tumor Macrophages
Kratochvill, F., Neale, G., Haverkamp, J. M., Van de Velde, L.-A., Smith, A. M., Kawauchi, D., McEvoy, J., Roussel, M. F., Dyer, M. A., Qualls, J. E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.033 · Cited by 277
Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps
von Köckritz-Blickwede, M., & Nizet, V. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0481-0 · Cited by 270
Jacobsen, E. A., Ochkur, S. I., Pero, R. S., Taranova, A. G., Protheroe, C. A., Colbert, D. C., Lee, N. A., & Lee, J. J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071840 · Cited by 263
Human non-small cell lung cancer cells express a type 2 cytokine pattern
(1996) · Lung Cancer · doi:10.1016/0169-5002(96)85851-x · Cited by 257
Immunotherapy of Cytotoxic T Cell–resistant Tumors by T Helper 2 Cells
Mattes, J., Hulett, M., Xie, W., Hogan, S., Rothenberg, M. E., Foster, P., & Parish, C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021683 · Cited by 256
Eosinophils in Helminth Infection: Defenders and Dupes
Huang, L., & Appleton, J. A. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.05.004 · Cited by 233
Tanizaki, J., Haratani, K., Hayashi, H., Chiba, Y., Nakamura, Y., Yonesaka, K., Kudo, K., Kaneda, H., Hasegawa, Y., Tanaka, K., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.10.030 · Cited by 225
Simson, L., Ellyard, J. I., Dent, L. A., Matthaei, K. I., Rothenberg, M. E., Foster, P. S., Smyth, M. J., & Parish, C. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4222 · Cited by 216
Gotlib, J. (2017) · American Journal of Hematology · doi:10.1002/ajh.24880 · Cited by 212
The Regulatory Function of Eosinophils
Wen, T., & Rothenberg, M. E. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0020-2015 · Cited by 208
Lucarini, V., Ziccheddu, G., Macchia, I., La Sorsa, V., Peschiaroli, F., Buccione, C., Sistigu, A., Sanchez, M., Andreone, S., D'Urso, M. T., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1317420 · Cited by 199
Heppt, M. V., Heinzerling, L., Kähler, K. C., Forschner, A., Kirchberger, M. C., Loquai, C., Meissner, M., Meier, F., Terheyden, P., Schell, B., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.05.038 · Cited by 199
Self-citationFloyd, H., Ni, J., Cornish, A. L., Zeng, Z., Liu, D., Carter, K. C., Steel, J., & Crocker, P. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.861 · Cited by 193
Cormier, S. A., Taranova, A. G., Bedient, C., Nguyen, T., Protheroe, C., Pero, R., Dimina, D., Ochkur, S. I., O’Neill, K., Colbert, D., et al. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0106027 · Cited by 176
Legrand, F., Driss, V., Delbeke, M., Loiseau, S., Hermann, E., Dombrowicz, D., & Capron, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000446 · Cited by 176
Pattern‐recognition receptors in human eosinophils
Kvarnhammar, A. M., & Cardell, L. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03556.x · Cited by 172
Astigiano, S., Morandi, B., Costa, R., Mastracci, L., D'Agostino, A., Ratto, G. B., Melioli, G., & Frumento, G. (2005) · Neoplasia · doi:10.1593/neo.04658 · Cited by 163
Tumour‐associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas
Dorta, R. G., Landman, G., Kowalski, L. P., Lauris, J. R. P., Latorre, M. R. D. O., & Oliveira, D. T. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01437.x · Cited by 161
Moreira, A., Leisgang, W., Schuler, G., & Heinzerling, L. (2017) · Immunotherapy · doi:10.2217/imt-2016-0138 · Cited by 147
Exosome secretion by eosinophils: A possible role in asthma pathogenesis
Mazzeo, C., Cañas, J. A., Zafra, M. P., Marco, A. R., Fernández‐Nieto, M., Sanz, V., Mittelbrunn, M., Izquierdo, M., Baixauli, F., Sastre, J., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.026 · Cited by 143
Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry
Stevens, W. W., Kim, T. S., Pujanauski, L. M., Hao, X., & Braciale, T. J. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.07.011 · Cited by 135
Malignant tumor and eosinophils: I. Prognostic significance in gastric cancer
Iwasaki, K., Torisu, M., & Fujimura, T. (1986) · Cancer · doi:10.1002/1097-0142(19860915)58:6<1321::aid-cncr2820580623>3.0.co;2-o · Cited by 134
Interleukin-5 Facilitates Lung Metastasis by Modulating the Immune Microenvironment
Zaynagetdinov, R., Sherrill, T. P., Gleaves, L. A., McLoed, A. G., Saxon, J. A., Habermann, A. C., Connelly, L., Dulek, D., Peebles, R. S., Fingleton, B., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2379 · Cited by 131
Throsby, M., Herbelin, A., Pléau, J.-M., & Dardenne, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1965 · Cited by 128
Generation of Th1 and Th2 Chemokines by Human Eosinophils: Evidence for a Critical Role of TNF-α
Liu, L. Y., Bates, M. E., Jarjour, N. N., Busse, W. W., Bertics, P. J., & Kelly, E. A. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4840 · Cited by 123
Hierarchical IL-5 Expression Defines a Subpopulation of Highly Differentiated Human Th2 Cells
Upadhyaya, B., Yin, Y., Hill, B. J., Douek, D. C., & Prussin, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101283 · Cited by 117
Eosinophils Oxidize Damage-Associated Molecular Pattern Molecules Derived from Stressed Cells
Lotfi, R., Herzog, G. I., DeMarco, R. A., Beer-Stolz, D., Lee, J. J., Rubartelli, A., Schrezenmeier, H., & Lotze, M. T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900504 · Cited by 111
Xie, F., Liu, L.-B., Shang, W.-Q., Chang, K., Meng, Y., Mei, J., Yu, J., Li, D., & Li, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.029 · Cited by 106
Biologic Therapies Targeting Eosinophils: Current Status and Future Prospects
Legrand, F., & Klion, A. D. (2015) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2015.01.013 · Cited by 105
Prizment, A. E., Vierkant, R. A., Smyrk, T. C., Tillmans, L. S., Lee, J. J., Sriramarao, P., Nelson, H. H., Lynch, C. F., Thibodeau, S. N., Church, T. R., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.42 · Cited by 105
Mouse Eosinophils Possess Potent Antibacterial Properties In Vivo
Linch, S. N., Kelly, A. M., Danielson, E. T., Pero, R. S., Lee, J. J., & Gold, J. A. (2009) · Infection and Immunity · doi:10.1128/iai.00306-09 · Cited by 103
Raney, R. B., Crist, W., Maurer, H. M., & Foulkes, M. A. (2006) · Cancer · doi:10.1002/1097-0142(19830701)52:1<126::aid-cncr2820520123>3.0.co;2-y · Cited by 95
Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors
Simon, S. C. S., Hu, X., Panten, J., Grees, M., Renders, S., Thomas, D., Weber, R., Schulze, T. J., Utikal, J. S., & Umansky, V. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1727116 · Cited by 95
Self-citationTumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma.
Ishibashi, S., Ohashi, Y., Suzuki, T., Miyazaki, S., Moriya, T., Satomi, S., & Sasano, H. (2006) · PubMed · Cited by 90
van Driel, W. J., Hogendoorn, P. C. W., Jansen, F. W., Zwinderman, A. H., Trimbos, J. B., & Fleuren, G. J. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90216-6 · Cited by 89
Gatault, S., Delbeke, M., Driss, V., Sarazin, A., Dendooven, A., Kahn, J., Lefèvre, G., & Capron, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402914 · Cited by 88
In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF
Bristol, J. A., Zhu, M., Ji, H. L., Mina, M., Xie, Y., Clarke, L., Forry‐Schaudies, S., & Ennist, D. L. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00103-5 · Cited by 87
Shimada, H., Newton, W. A., Soule, E. H., Beltangady, M. S., & Maurer, H. M. (1987) · Cancer · doi:10.1002/1097-0142(19870201)59:3<466::aid-cncr2820590319>3.0.co;2-p · Cited by 71
Huland, E., & Huland, H. (1992) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01629431 · Cited by 70
Wei, Y., Zhang, X., Wang, G., Zhou, Y., Luo, M., Wang, S., & Hong, C. (2018) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12871 · Cited by 69
Pandit, R., Scholnik, A. P., Wulfekuhler, L., & Dimitrov, N. S. (2006) · American Journal of Hematology · doi:10.1002/ajh.20789 · Cited by 68
Hirai, H., Fujishita, T., Kurimoto, K., Miyachi, H., Kitano, S., Inamoto, S., Itatani, Y., Saitou, M., Maekawa, T., & Taketo, M. M. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9684-z · Cited by 68
Steel, J. L., Kim, K. H., Dew, M. A., Unruh, M. L., Antoni, M. H., Olek, M. C., Geller, D. A., Carr, B. I., Butterfield, L. H., & Gamblin, T. C. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.09.019 · Cited by 67
Eosinophil ablation and tumor development
Wong, D. T., Bowen, S., Elovic, A., Gallagher, G. T., & Weller, P. F. (1999) · Oral Oncology · doi:10.1016/s1368-8375(99)00023-8 · Cited by 64
Eosinophils in Colorectal Neoplasms Associated with Expression of CCL11 and CCL24
Cho, H., Lim, S., Won, K. Y., Bae, G. E., Kim, G. Y., Min, J. W., & Noh, B. (2015) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2015.10.16 · Cited by 64
Ultrastructural evidence for human mast cell-eosinophil interactions in vitro
Minai‐Fleminger, Y., Elishmereni, M., Vita, F., Soranzo, M. R., Mankuta, D., Zabucchi, G., & Levi‐Schaffer, F. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1010-8 · Cited by 63
Curran, C. S., Evans, M. D., & Bertics, P. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001965 · Cited by 63
Eosinophils induce DC maturation, regulating immunity
Lotfi, R., & Lotze, M. T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607366 · Cited by 61
Prizment, A. E., Anderson, K. E., Visvanathan, K., & Folsom, A. R. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0360 · Cited by 59
Scanvion, Q., Béné, J., Gautier, S., Grandvuillemin, A., Le Beller, C., Chenaf, C., Etienne, N., Brousseau, S., Cortot, A. B., Mortier, L., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1722022 · Cited by 59
Lorena, S., Oliveira, D., Dorta, R., Landman, G., & Kowalski, L. (2003) · Oral Diseases · doi:10.1034/j.1601-0825.2003.00958.x · Cited by 58
Bedoya, V. I., Boasso, A., Hardy, A. W., Rybak, S. M., Shearer, G. M., & Rugeles, M. T. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.897 · Cited by 56
The role of eosinophil major basic protein in angiogenesis
Puxeddu, I., Berkman, N., Nissim Ben Efraim, A. H., Davies, D. E., Ribatti, D., Gleich, G. J., & Levi‐Schaffer, F. (2009) · Allergy · doi:10.1111/j.1398-9995.2008.01822.x · Cited by 53
McNeel, D. G., Gardner, T. A., Higano, C. S., Kantoff, P. W., Small, E. J., Wener, M. H., Sims, R. B., DeVries, T. A., Sheikh, N. A., & Dreicer, R. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0073 · Cited by 53
Tissue Eosinophilia and its Association with Tumoral Invasion of Oral Cancer
Oliveira, D. T., Tjioe, K. C., Assáo, A., Faustino, S. E. S., Carvalho, A. L., Landman, G., & Kowalski, L. P. (2009) · International Journal of Surgical Pathology · doi:10.1177/1066896909333778 · Cited by 51
Sosman, J. A., Bartemes, K. R., Offord, K. P., Kita, H., Fisher, S. G., Kefer, C., Ellis, T. A., Fisher, R. I., Higgins, T., & Gleich, G. J. (1995) · PubMed · Cited by 50
Primary immunodeficiencies associated with eosinophilia
Navabi, B., & Upton, J. E. M. (2016) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-016-0130-4 · Cited by 50
Tissue Eosinophilic Infiltration
Alrawi, S., Tan, D., Staler, D. L., Dayton, M. T., Anderson, G. R., Mojica‐Manosa, P., Douglas, W. G., Hicks, W. L., Rigual, N., & Loree, T. R. (2005) · The Cancer Journal · doi:10.1097/00130404-200505000-00008 · Cited by 49
Caruso, R. A., Parisi, A., Quattrocchi, E., Scardigno, M., Branca, G., Parisi, C., Lucianò, R., Paparo, D., & Fedele, F. (2011) · Ultrastructural Pathology · doi:10.3109/01913123.2011.578233 · Cited by 49
Influence of pathological tumour variables on long-term survival in resectable gastric cancer
Party, O. B. O. T. M. U. G. C. W., Cuschieri, A., Talbot, I. C., & Weeden, S. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600161 · Cited by 48
Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry
Dyer, K. D., Garcia-Crespo, K. E., Killoran, K. E., & Rosenberg, H. F. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.04.009 · Cited by 46
Vesicular transport of peroxidase in human eosinophilic myelocytes
Dvořàk, A. M., Estrella, P., & Ishizaka, T. (1994) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1994.tb00910.x · Cited by 43
ATP drives eosinophil effector responses through P2 purinergic receptors
Kobayashi, T., Soma, T., Noguchi, T., Nakagome, K., Nakamoto, H., Kita, H., & Nagata, M. (2015) · Allergology International · doi:10.1016/j.alit.2015.04.009 · Cited by 41
Cytotoxic Properties of Eosinophil Granule Major Basic Protein for Tumor Cells
Kubo, H., Loegering, D. A., Adolphson, C. R., & Gleich, G. J. (1999) · International Archives of Allergy and Immunology · doi:10.1159/000024154 · Cited by 39
Stromal Eosinophilia in Colonic Epithelial Neoplasms
Moezzi, J., Gopalswamy, N., Haas, R., Markert, R. J., Suryaprasad, S., & Bhutani, M. S. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01778.x · Cited by 39
Bethwaite, P., Holloway, L., Yeong, M., & Thornton, A. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.11.1016 · Cited by 37
Eosinophils may predict occult lymph node metastasis in early oral cancer
Oliveira, D. T., Biassi, T. P., Faustino, S. E. S., Carvalho, A. L., Landman, G., & Kowalski, L. P. (2011) · Clinical Oral Investigations · doi:10.1007/s00784-011-0651-7 · Cited by 35
Murine hypodense eosinophils induce tumour cell apoptosis by a granzyme B-dependent mechanism
Costain, D. J., Guha, A. K., Liwski, R., & Lee, T. D. G. (2001) · Cancer Immunology Immunotherapy · doi:10.1007/pl00006690 · Cited by 35
Clinical Impact of Tumor-Infiltrating Inflammatory Cells in Primary Small Cell Esophageal Carcinoma
Zhang, Y., Ren, H., Wang, L., Ning, Z., Zhuang, Y.-X., Gan, J., Chen, S., Zhou, D., Zhu, H., Tan, D., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069718 · Cited by 34
CCL 11‐induced eosinophils inhibit the formation of blood vessels and cause tumor necrosis
Xing, Y., Tian, Y., Kurosawa, T., Matsui, S., Touma, M., Yanai, T., Wu, Q., & Sugimoto, K. (2016) · Genes to Cells · doi:10.1111/gtc.12371 · Cited by 33
Gündüz, Ş., Göksu, S. S., Arslan, D., Tatlı, A. M., Uysal, M., Gündüz, U. R., Sevinc, M. M., Çoşkun, H. Ş., Bozcuk, H. S., Mutlu, H., et al. (2015) · Molecular and Clinical Oncology · doi:10.3892/mco.2015.610 · Cited by 25
TLR ‐Stimulated Eosinophils Mediate Recruitment and Activation of NK Cells In Vivo
O'Flaherty, S. J., Sutummaporn, K., Häggtoft, W. L., Worrall, A. P., Rizzo, M., Braniste, V., Höglund, P., Kadri, N., & Chambers, B. J. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12554 · Cited by 24
da Silva, J. M., Queiroz‐Junior, C. M., Batista, A. C., Rachid, M. A., Teixeira, M. M., & Silva, T. A. (2014) · PubMed · doi:10.14670/hh-29.387 · Cited by 21
Eosinophilia is a favorable prognostic marker for oral cavity and lip squamous cell carcinoma
Peurala, E., Tuominen, M., Löyttyniemi, E., Syrjänen, S., & Rautava, J. (2018) · Apmis · doi:10.1111/apm.12809 · Cited by 21
Rakesh, N., Devi, Y. B., Majumdar, K., Reddy, S., & Agarwal, K. (2015) · Journal of Clinical and Experimental Dentistry · doi:10.4317/jced.51610 · Cited by 17
Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast Cancer
Wistuba‐Hamprecht, K., Gouttefangeas, C., Weide, B., & Pawelec, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01152 · Cited by 17
Wang, H., Wan, F., Gu, W., Zhu, Y., Dai, B., Shi, G., Zhang, H., & Ye, D. (2016) · Oncotarget · doi:10.18632/oncotarget.12126 · Cited by 15
Does the severity of tissue eosinophilia of colonic neoplasms reflect their malignancy potential?
KIZILTAŞ, Ş., Sezgin Ramadan, S., Topuzoǧlu, A., & Küllü, S. (2008) · The Turkish Journal of Gastroenterology · Cited by 12
Jain, D., Tikku, G., Bhadana, P., Dravid, C., & Grover, R. K. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-017-0328-x · Cited by 10
Moreira, A., Erdmann, M., Uslu, U., Vass, V., Schuler, G., & Schuler‐Thurner, B. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030210 · Cited by 10
Górriz-Gil, C., Royo, V. M., Álvarez-Montero, Ó., Valiente, A. R., Manzano, C. F., García, B. C., & García‐Berrocal, J. R. (2018) · HNO · doi:10.1007/s00106-018-0516-3 · Cited by 6
Peripheral blood eosinophil count correlates with survival in lung cancer
Shelton, A., Green, R. H., Bradding, P. H., & FREE, C. M. (2010) · Lung Cancer · doi:10.1016/s0169-5002(10)70123-9 · Cited by 4
Furbert-Harris, P. M., Smith, M. A., Law, M. P., Currie, E., Young, J. M., Gause, D. P., Vaughn, T. R., Harris, V. L., & Oredipe, O. A. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000190967.73030.72 · Cited by 2
Hollande, C., da Silva, R. B., Bondet, V., Llibre, A., Duffy, D., Mallet, V. O., Pol, S., & Albert, M. L. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)30748-1 · Cited by 1
Research works printed but not linked: 1
- Feldbausch F (1900) The occurrence of eosinophilic leukocytes in tumours. Archiv Fur Pathologische Anatomie Physiologie Fur Klinische Medicin 161(1):1–18
Cited by
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
“Eosinophils are commonly seen in the TME (96, 97).”
BackgroundSalemme, V., Centonze, G., Cavallo, F., Defilippi, P., & Conti, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.610303 · Cited by 247
Contributions of Eosinophils to Human Health and Disease
Klion, A. D., Ackerman, S. J., & Bochner, B. S. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032756 · Cited by 244
“Some of the more intriguing recent information on this topic comes from analyses of tumor biopsies and correlations between prognosis and numbers of eosinophils in the tumor microenvironment, detected histologically or based on the presence of eosinophil-specific gene signatures (74, 75).”
BackgroundŞahin, T. K., Ayasun, R., Rizzo, A., & Güven, D. C. (2024) · Cancers · doi:10.3390/cancers16213689 · Cited by 186
“Neutrophils and eosinophils, both integral components of the immune system, play distinct yet interconnected roles in cancer progression [18,19].”
BackgroundHwang, M., Canzoniero, J. V., Rosner, S., Zhang, G., White, J. R., Belcaid, Z., Cherry, C., Balan, A., Pereira, G., Curry, A., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004688 · Cited by 150
Metadata
- Authors
- Simon, S. C. S., Utikal, J., & Umansky, V.
- Affiliations
- German Cancer Research Center (DE)
- Corresponding author
- Umansky, Viktor
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2018-10-09
- Volume
- 68
- Issue
- 5
- Pages
- 823-833
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- PMC
- PMC11028063
- OpenAlex
- W2896948312
- Semantic Scholar
- 51d1f88740bcf0f7ea77a0ef42febece0d7266cd
- Cited by
- 128
- References
- 110
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 17 · 2023: 14 · 2022: 23 · 2021: 30 · 2020: 21 · 2019: 9
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer Immunology Immunotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (RTG2099)
- Deutsches Krebsforschungszentrum (CA181)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- eosinophils, tumor microenvironment, antitumor immunity, tumor-associated tissue eosinophilia, prognostic factors, predictive biomarkers, immune checkpoint inhibitors, cancer immunotherapy, eosinophil-targeted therapy, granulocytes
- MeSH terms
- Cytotoxicity, Immunologic, Eosinophils, Humans, Hypersensitivity, Immunotherapy, Neoplasms, Parasitic Diseases, Prognosis, Biomarkers, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.